Anne-marie Axø Gerdes - Genetic Mutations

Author Information

Anne-marie Axø Gerdes is a distinguished researcher affiliated with the Department of Clinical Genetics at Rigshospitalet, Copenhagen University Hospital, in Copenhagen, Denmark. Her work primarily focuses on genetics, with a particular emphasis on cancer genetics and genetic screening.

Research Contributions

Anne-marie Axø Gerdes has made significant contributions to the field of genetics, particularly in cancer research. Her recent work includes population-based whole-genome sequencing to identify predisposing germline variants in children with central nervous system tumors and the identification of rare genetic variants in familial pancreatic cancer patients. She has also explored the role of immune cells as predictive markers in BRCA1- and BRCA2-associated breast cancer and conducted studies on genetic screening for prospective parents and adopted individuals. Additionally, she has investigated public knowledge and attitudes towards direct-to-consumer genetic testing and examined sun-related behaviors in melanoma-prone families. Her research is widely recognized and has garnered a substantial citation count, reflecting its impact on the field.

Aliases

Anne-marie Axø Gerdes is also known by several other names in academic circles, including A. M. Gerdes, A.-m. Gerdes, Anne-marie Gerdes, and Anne Marie Gerdes. These aliases reflect variations in the presentation of her name across different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	243
Total Citations	10,481
h-index	48

Publications:

Population-based whole-genome sequencing with constrained gene analysis identifies predisposing germline variants in children with central nervous system tumors

DOI: 10.1101/2022.03.01.22271578

Year: 2022

Whole genome sequencing identifies rare genetic variants in familial pancreatic cancer patients.

DOI: 10.1111/ahg.12464

Year: 2022

[Genetic screening of prospective parents].

DOI:

Year: 2021

[Genetic screening of adopted individuals].

DOI:

Year: 2021

Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer.

DOI: 10.1038/s41416-021-01514-7

Year: 2021

Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

DOI: 10.1007/s10689-021-00254-0

Year: 2021

Direct to consumer genetic testing in Denmark-public knowledge, use, and attitudes.

DOI: 10.1038/s41431-021-00810-3

Year: 2021

Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families

DOI: 10.1186/s12889-021-10424-5

Year: 2021

Su291 WHOLE GENOME SEQUENCING OF FIRST-DEGREE RELATIVES OF PATIENTS WITH FAMILIAL PANCREATIC CANCER IDENTIFIES GENES AND FUNCTIONAL PATHWAYS ENRICHED IN RARE GENETIC VARIANTS

DOI: 10.1016/S0016-5085(21)02291-5

Year: 2021

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.

DOI: 10.1016/S1470-2045(21)00189-3

Year: 2021

What is PacBio?

How is Karyotyping Performed?

What Role does Genetic Counseling Play?

What are Common Applications of Gene Cloning?

How is Sickle Cell Disease Inherited?

What is CRISPR-Cas9?

What Are the Common PARP Inhibitors?

Do Synonymous Mutations Affect Gene Expression?

What Evidence Supports the Neutral Theory?

How Do Mutant Genes Affect Organisms?

Partnered Content Networks

Relevant Topics